TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,089 JPY | -0.02% |
|
+0.49% | +0.86% |
| 26/04 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
| 26/04 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 4,219.00 | 4,482.00 | 4,860.00 |
| Spread/Res. | -3.08% | -8.77% | -15.86% |
| Spread/Supp. | +0.79% | +4.07% | +2.35% |
| Support | 4,057.00 | 3,929.00 | 3,995.00 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 4502 Stock
- Charts Takeda Pharmaceutical Company Limited
